#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Candida infection Leukoencephalopathy CDKL5 deficiency disorder Ichthyosis Primary amyloidosis Pancreatic neuroendocrine tumour Metastatic gastric cancer Selective polysaccharide antibody deficiency Bulbospinal muscular atrophy congenital Rhabdomyosarcoma Cardiomyopathy Cholestatic pruritus Vulval cancer recurrent Leber's congenital amaurosis Biliary cancer metastatic More trials…

    Learn about Rare Diseases

    Arterial tortuosity syndrome – Diagnostics Arterial tortuosity syndrome – Life with Disease Arterial tortuosity syndrome – Trials in Disease Atypical haemolytic uraemic syndrome Hyperoxaluria – Life with Disease Atypical haemolytic uraemic syndrome – Basic Information Osteosarcoma metastatic – Treatment Pemphigoid – Treatment Mantle cell lymphoma stage IV – Diagnostics Alexander disease – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Aciclovir Triheptanoin Gskvx000000017033 OXYBUTYNIN HYDROCHLORIDE Nomegestrol Acetate Ucart22 Posaconazole Itraconazole Perindopril Arginine Nivolumab Nacubactam TROFOLASTAT Sodium Alginate Eptinezumab Vibostolimab BMS-986470 Apitegromab Thiamazole Prax-628 ATUMELNANT More therapies…

    Learn about Your Condition

    Pyoderma Eclampsia Immunodeficiency congenital Hypercholesterolaemia Inflammation Bronchiectasis Rabies Hydrocephalus Neurogenic bladder Alcohol abuse Metastatic glioma Labour pain Endometrial cancer stage II Rectal neoplasm Biotinidase deficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopitaux Universitaires Pitie Salpetriere

Hopitaux Universitaires Pitie Salpetriere

47 Boulevard De L Hopital, Paris, 75651, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Darolutamide and Triptorelin for Patients with Localized High-Risk Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Prostate cancer
    Investigated Drugs:
    • Darolutamide
    • Triptorelin
    France Spain

  • Study on the Effects of Tacrolimus and Mycophenolate Mofetil in Patients After Liver Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Liver transplant
    Investigated Drugs:
    • Mycophenolate Mofetil
    • Tacrolimus
    France

  • Comparison of belantamab mafodotin, bortezomib and dexamethasone versus daratumumab, bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Belantamab Mafodotin
    • Bortezomib
    • Daratumumab
    Belgium Czechia France Germany Greece Italy +3

  • Study Comparing Two Treatment Strategies for Intermediate-Risk Thyroid Cancer Using Sodium Iodide (131I) in Patients with Post-Surgery Evaluation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Follicular thyroid cancer
    • Papillary thyroid cancer
    • Thyroid cancer
    Investigated Drugs:
    • Sodium Iodide (131I)
    France

  • Study of Paclitaxel, Carboplatin, and Bevacizumab with Niraparib for Patients with Advanced Ovarian, Tubal, or Peritoneal Cancer After Surgery

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Niraparib
    • Niraparib Tosilate Monohydrate
    • Bevacizumab
    Belgium France Italy Spain

  • Study on ATX-01 for Adults Aged 18-64 with Myotonic Dystrophy Type 1 (DM1)

    Recruiting

    1 1
    Investigated Drugs:
    • 16-Base Single Stranded Rna Targeting Mir-23B Linked To Oleic Acid
    France Italy The Netherlands Spain

  • Study on Treating Resistant Viral Infections in Stem Cell Transplant Patients Using Allogeneic Multivirus-Specific T Cells

    Recruiting

    3 1
    Investigated Diseases:
    • Adenovirus infection
    • Cytomegalovirus infection
    • Epstein-Barr virus infection
    Investigated Drugs:
    • Allogeneic Cd4+ And Cd8+ T Lymphocytes Ex Vivo Incubated With Synthetic Peptides Of The Viral Antigens Of Cytomegalovirus, Adenovirus And Epstein-Barr Virus
    Belgium France Germany Italy The Netherlands

  • Study on Nipocalimab for Adults with Generalized Myasthenia Gravis

    Recruiting

    3 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Nipocalimab
    Belgium Czechia Denmark France Germany Italy +3

  • Study on the Effects of Metreleptin for Patients with Partial Lipodystrophy

    Recruiting

    3 1 1 1 1
    Investigated Diseases:
    • Partial lipodystrophy
    Investigated Drugs:
    • Metreleptin
    France Germany Italy

  • Study on the Effectiveness of Dazukibart in Adults with Active Dermatomyositis or Polymyositis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Dermatomyositis
    • Polymyositis
    Investigated Drugs:
    • Betamethasone
    • CHLOROQUINE PHOSPHATE
    • Dazukibart
    Belgium Bulgaria France Germany Hungary Italy +4
Previous Page
1 … 4 5 6 7 8 … 20
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!